Inactivating mutations of proapoptotic Bad gene in human colon cancers

• Published in: Carcinogenesis (New York) 2004-08, Vol.25 (8), p.1371-1376
• Main Authors: Lee, Jong Woo, Soung, Young Hwa, Kim, Su Young, Nam, Suk Woo, Kim, Chang Jae, Cho, Yong Gu, Lee, Jong Heun, Kim, Hong Sug, Park, Won Sang, Kim, Sang Ho, Lee, Jung Young, Yoo, Nam Jin, Lee, Sug Hyung
• Format: Article
• Language: English
• Subjects: Alleles; Alternative Splicing; Apoptosis; Bad; Bcl-2 homology; Bcl-2 homology3; bcl-Associated Death Protein; bcl-X Protein; Bcl-XL/Bcl-2-associated death promoter; BH3; Biological and medical sciences; Carcinogenesis, carcinogens and anticarcinogens; Carrier Proteins - genetics; Cell Line; Cell Line, Tumor; Colonic Neoplasms - genetics; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Exons; Humans; Immunoblotting; Immunohistochemistry; Medical sciences; Mutagenesis, Site-Directed; Mutation; Mutation, Missense; PCR; Plasmids - metabolism; polymerase chain reaction; Polymorphism, Single-Stranded Conformational; Precipitin Tests; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2 - metabolism; Sequence Analysis, DNA; single strand conformation polymorphism; SSCP; Transfection; Tumors
• ISSN: 0143-3334; 1460-2180
• DOI: 10.1093/carcin/bgh145

Evidence exists that deregulation of apoptosis is involved in the mechanisms of cancer development, and the somatic mutations of apoptosis-related genes have been reported in human cancers. Bcl-XL/Bcl-2-associated death promoter (Bad), a proapoptotic member of Bcl-2 family, plays an important role in the intrinsic apoptosis pathway. To explore the possibility that the genetic alterations of Bad might be involved in the development of human cancers, we analyzed the entire coding region and all splice sites of human Bad gene in 47 colon adenocarcinomas. Overall, we detected two somatic missense mutations (4.3%) in Bad gene. Interestingly, both of the Bad mutations were detected in the gene sequences encoding the Bcl-2 homology3 domain of Bad, which has a crucial role in inducing cell death. Transfection study revealed that both of the tumor-derived Bad mutants had decreased apoptosis activities compared with the wild-type Bad, indicating that the Bad mutations reduced the cell death function of Bad. Co-immunoprecipitation assay revealed that binding of one of the tumor-derived Bad mutants with Bcl-2 and Bcl-XL is reduced. This is the first report on Bad gene mutation in human malignancies, and our data suggest that Bad gene is occasionally mutated in colon cancers and that somatic mutation of Bad may contribute to the development of colon cancers.